Intrinseque Health

Linkedin Facebook Youtube
LOGO - Registered (7)
Menu
INTRINSEQUE HEALTH (2)

About Us

We Build & Execute Complex Clinical Supply Plans

Intrinseque Health is an EN ISO 13485 Certified Global clinical trial support services provider committed to the utmost in service delivery to drug development organizations (Pharmaceutical, Biotechnology, Medical Device & Contract Research Organizations (CROs)). Our team of industry professionals has over 300 years of combined experience supporting global clinical trials across a wide array of therapeutic areas. This vast experience enables us to empathize with our Customers while providing best-in-class solutions to overcome the hurdles and pain-points of conducting a clinical trial.

Regions & countries throughout the world will often present a unique set of regulatory and logistical challenges. It is our responsibility to understand and overcome these while ensuring that your products, supplies, equipment and services are available where needed to ensure study timelines are met. Intrinseque Health utilizes an operational methodology that is based on proven, cost-effective clinical supply chain strategy for each clinical trial. Our practice is to engage with our Customers, early and often to ensure implementation of a robust clinical supply plan, resulting in the most successful study start-up and initiation.

MISSION

To create, implement, and execute efficient and effective clinical supply planning and robust sourcing strategies to meet clinical development and study timelines by ensuring essential supplies, equipment, and services are made available and managed at clinical trial sites on time, thereby ensuring the success of clinical trials.

VISION

To be the leading and trusted global vendor of clinical trial support services by consistently reducing risks, navigating regulatory challenges, and undertaking successful clinical trial supplies projects. Our ability to constantly evolve, innovate, and adopt tailored solutions helps our customers in bringing their products to the market sooner.